Newsletter copywriters are no different from other marketers: they will do whatever it takes to get attention by playing off of something or someone that has celebrity or notoriety. In the past that’s meant implying that some big celebrity investor has a connection to a “secret” stock or technique, or that someone high up in […]
Articles
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
Stansberry research Tim Phaeln at investors alley Contrarian outlook...
I have been disappointed in Fitzg's newsletter. But I have picked up good advice from Tim Plaehn's Investors' Alley. He...
From Bret Jensen of Investors Alley: Amicus Therapeutics (NASDAQ: FOLD), another attractive small biotech concern se...
Well, thats a switch. Ordinarily I'd say I've gotten some of the worst advice from Investors Alley in the last year....
I still subscribe to The Oxford Income Letter. It's still okay and I do like reading their take on the markets. I am al...
Change of subject, I received an email from Investor's Alley saying that 19 major banks to shut down. Do you have any c...
(Do your own Due Diligence: No position in either company - KennyG) 2 Attractive Small-Cap Biotech Stocks On The Verge ...
Hi Rae: I happened to be awake because the any-minute coming of Santa Claus excites me. $EW is a classy company whose...
$EW Dr. KSS what is your opinion of $EW - Edwards Lifesciences. It quietly goes about its business with very little p...